Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at ACA's multiple
$2.3341.6% below market
0.94 ZNTL revenue / share×2.48x ACA P/S=$2.33
Market $3.99Implied $2.33
ACA · current priceP/S 2.48x
$145.45Latest market snapshot
Implied fair value · at ZNTL's multiple
$249.0471.2% above market
58.72 ACA revenue / share×4.24x ZNTL P/S=$249.04
Market $145.45Implied $249.04